Anthropic is opening applications for its AI for Science program focused on rare genetic diseases, offering up to $50,000 in Claude credits over six months. The initiative aims to build a community of researchers exploring how AI can reshape the understanding and treatment of these conditions.
- Track one supports basic science partnerships with organizations like the Monarch Initiative to discover mechanisms underlying rare diseases using resources such as DisMech.
- Track two assists early-stage biotechs in accelerating clinical development by compressing regulatory documentation timelines and identifying shared therapeutic targets.
- Applications are accepted through August 2, 2026, for projects utilizing Claude Opus or other approved models.
The program seeks to address the challenges of limited data and scattered patient populations by leveraging AI to synthesize findings and accelerate drug development processes.